[Treatment of Hodgkin's disease including the staging laparotomy]. 1984

T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto

UI MeSH Term Description Entries
D007813 Laparotomy Incision into the side of the abdomen between the ribs and pelvis. Minilaparotomy,Laparotomies,Minilaparotomies
D008297 Male Males
D008466 Mechlorethamine A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA. Chlorethazine,Chlormethine,Mechlorethamine Oxide,Mustine,Nitrogen Mustard,Nitrogen Mustard N-Oxide,Bis(2-chloroethyl)methylamine,Caryolysine,Cloramin,Embichin,Mechlorethamine Hydrochloride,Mechlorethamine Hydrochloride N-Oxide,Mechlorethamine N-Oxide,Methylchlorethamine,Mitomen,Mustargen,NSC-10107,NSC-762,Nitrogranulogen,Nitromin,Hydrochloride N-Oxide, Mechlorethamine,Hydrochloride, Mechlorethamine,Mechlorethamine Hydrochloride N Oxide,Mechlorethamine N Oxide,N-Oxide, Mechlorethamine Hydrochloride,N-Oxide, Nitrogen Mustard,NSC 10107,NSC 762,NSC10107,NSC762,Nitrogen Mustard N Oxide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma

Related Publications

T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto
March 1973, The Medical clinics of North America,
T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto
January 1980, Acta chirurgica Scandinavica,
T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto
January 1982, International surgery,
T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto
February 1978, Nursing mirror,
T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto
February 1981, The Australian and New Zealand journal of surgery,
T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto
May 1976, The American surgeon,
T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto
March 1981, Archives of surgery (Chicago, Ill. : 1960),
T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto
May 1980, Annals of surgery,
T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto
May 1982, Fortschritte der Medizin,
T Yosida, and J Nakanisi, and S Kobayasi, and S Ohtake, and K Ito, and S Nakamura, and K Hattori, and Y Saito, and K Tanimoto
May 1978, Annals of surgery,
Copied contents to your clipboard!